Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/1999
11/03/1999EP0596984B1 Preparation of microparticles
11/03/1999CN1233505A Enterogastric negative radiography agent and prodn. method therefor
11/03/1999CN1046094C Use of holoside for preparing in-site gelate, ophthalmic composition
11/02/1999US5978698 Angioplasty procedure using nonionic contrast media
11/02/1999US5977353 1,4,7,10-tetraazabicyclo[8.2.2]tetradecan-2-one, a process for the preparation thereof and the use thereof for the preparation of tetraazamacrocycles
11/02/1999US5977323 Purifying inflammatory cytokine/chemokine by immunoaffinity chromatography; complexing chemokine to anti-gro antibodies bound to matrix, eluting chemokine
11/02/1999US5977159 Medical use of an ace-inhibitor for treatment of dyspeptic symptoms
11/02/1999US5976502 Using a scanning laser ophthalmoscope
11/02/1999US5976501 Use of pressure resistant protein microspheres encapsulating gases as ultrasonic imaging agents for vascular perfusion
11/02/1999US5976500 Administering gel particles of a polymer entrapping at least one contrast enhancing metal; scanning the patient
11/02/1999US5976499 Macroscopic sweat test for cystic fibrosis
11/02/1999US5976498 Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands
11/02/1999US5976495 Peptide derived radionuclide chelators
11/02/1999US5976493 Metabolically cleavable dendrimeric polychelants
11/02/1999US5976093 Vascular catheter having low-profile distal end
10/1999
10/28/1999WO1999053965A1 Improvements in or relating to contrast agents
10/28/1999WO1999053964A1 Ultrasound contrast agent dispersions comprising gas and destabilising agent
10/28/1999WO1999053963A1 Improvements in or relating to contrast agents
10/28/1999WO1999053962A1 Solution for diagnosing or treating tissue pathologies
10/28/1999CA2329175A1 Improvements in or relating to contrast agents
10/27/1999EP0952216A2 Solid phase supports with PNA and amidate tag compliments
10/27/1999EP0951912A2 Assessment of ischemic wound healing therapeutics
10/27/1999EP0951478A1 Polysaccharide-peptide derivatives
10/27/1999EP0951292A1 Methods for treating an ischemic disorder and improving stroke outcome
10/26/1999US5972987 Detection lice with dye
10/26/1999US5972890 Polypeptide with label; diagnosis
10/26/1999US5972646 Isolated nucleic acid molecule which codes for a 32 kDa protein having 11-cis retinol dehydrogenase activity, and which associates with P63, a portion of a retinol binding protein receptor
10/26/1999US5972338 ?tie? or ?tie? are acronyms, which stand for ?tyrosine kinase containing ig and egf homology domains?; present invention concerns novel human tie ligand homologues with powerful effects on vasculature; antitumor agents
10/26/1999US5972337 46 kilodalton human milk fat globule (HMFG) antigen, fragments and fusion protein
10/26/1999US5972309 Identification of an exogenous intra-erythrocytic bacterium in patients having systemic lupus erythematosus, and treatment
10/26/1999US5972308 Reacting technetium-99 with a cyclic oligopeptide having amino acid units containing a mercaptan group attached to the ring through a homocysteine unit.
10/26/1999US5972307 Administering to human or animal body an effective amount of a diagnostic agent comprises a metal chelate of a compound having two macrocyclic chelant groups linked by a bridge containing ester or amide bond
10/26/1999CA2119345C Methods for the in vivo measurement of the concentration of nmr-detectable xenobiotic compounds
10/21/1999WO1999052858A2 Lipids
10/21/1999WO1999052564A1 Method
10/21/1999WO1999052541A2 Artery- and vein-specific proteins and uses therefor
10/21/1999WO1999052505A1 Use of particulate contrast agents in diagnostic imaging for studying physiological parameters
10/21/1999WO1999052428A1 In vivo magnetic resonance vascular imaging using laser-polarized gas microbubbles
10/21/1999WO1999015654A3 Tie receptor tyrosine kinase ligand homologues
10/21/1999DE19916896A1 Particles for chelating metal ions, useful in cosmetic, pharmaceutical and food products and products for treating liquids, especially water
10/21/1999DE19816922A1 Synthetic cyclic peptides used as models for conformational analysis and as potential drugs
10/21/1999CA2327816A1 Use of particulate contrast agents in diagnostic imaging for studying physiological parameters
10/21/1999CA2325563A1 Artery- and vein-specific proteins and uses therefor
10/20/1999EP0950065A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases
10/20/1999EP0949932A1 Use of hollow microcapsules in diagnosis and therapy
10/20/1999EP0949917A1 Substances and their uses
10/20/1999EP0754009A4 Magnetic resonance imaging using hyperpolarized noble gases
10/20/1999CN1231927A Quick soluble imaging assistant for gastrointestinal ultrasonic diagnosis, and its preparing process
10/20/1999CN1045772C Polyazacycloalkanes as dichelants
10/19/1999US5969116 Ribo-nucleoside analogues the 2'-oh group etherified, and having a radical forming a phosphorous or ether-containing nucleotide bridge group, capable of base pairing with a complementary nucleic acid strand; binding affinity
10/19/1999US5969111 Radiation sensistizers
10/19/1999US5968479 Indole, fluorescent, and cyanine dyes; infrared endoscopy
10/19/1999CA1340790C Method of diagnosis and severity-assessment of human pancreatic disease
10/14/1999WO1999051994A1 Pharmacological mri (phmri)
10/14/1999WO1999051284A2 Non-covalent bioconjugates useful for diagnosis and therapy
10/14/1999WO1999051234A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051232A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999042076A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/14/1999DE19816370A1 New manganese complexes useful as low-toxicity contrast agents for magnetic resonance imaging
10/14/1999CA2327705A1 Pharmacological mri (phmri)
10/14/1999CA2326650A1 Azo and diaza dericatives and uses thereof in phototherapy
10/14/1999CA2326143A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326139A1 Antagonists of gonadotropin releasing hormone
10/13/1999EP0948361A1 Magnetic resonance blood pool agents
10/13/1999EP0692977B1 Novel heterocycle based nitrogen-sulfur ligands useful in radiographic imaging agents
10/13/1999EP0588869B1 X-ray contrast agent
10/12/1999US5965721 With improved nuclease resistance and improved cellular uptake; for antisense agents and regulation of rna expression
10/12/1999US5965383 Fibrin binding domain polypeptides and uses and methods of producing same
10/12/1999US5965382 Nucleic acid encoding secreted Mac-2 binding glycoprotein
10/12/1999US5965136 Bone resorption assay
10/12/1999US5965133 Self-assembling multimeric nucleic acid constructs
10/12/1999US5965132 Methods and compositions for targeting the vasculature of solid tumors
10/12/1999US5965131 Galactosylated clearing agent binds to the primary binding site of the primary targeting species, and only non-bound primary targeting species is cleared, not bound species second site is not blocked by the clearing agent
10/12/1999US5965109 Saturating an insoluble gas with a hydrophobic compound; during conventional cavitation, hydrophobic compound condenses or reacts with shell material to form a hydrophobic barrier, imparting pressure resistance and stability
10/12/1999US5965108 Cyclic peptide-metal complex specifically binds to surface somatostatin receptor-expressing cells; radiology; scintigraphy; antitumor,-carcinogenic and metastatic agents; stability
10/07/1999WO1999049899A2 Diagnostic imaging of vascular abnormalities using vasomodification
10/07/1999WO1999049880A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999WO1999049716A2 Method for producing liposomal formulations of active agents by high-pressure homogenisation
10/07/1999CA2326588A1 Methods for treating an ischemic disorder and improving stroke outcome
10/06/1999EP0946712A1 Method for producing transgenic animal models with modulated phenotype and animals produced therefrom
10/06/1999EP0946526A1 Macrocyclic metal complex carboxylic acids, use and method for the production thereof
10/06/1999EP0946525A1 Method for producing metal complex carboxylic acid amides
10/06/1999EP0946203A1 Tricyclic functional dyes for contrast enhancement in optical imaging
10/06/1999EP0946202A2 Contrast agents
10/06/1999EP0779933A4 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
10/06/1999CN1230438A Developer for supersonic diagnosis of oviduct and its use
10/05/1999US5962216 Tumor-activated prodrug compounds and treatment
10/05/1999US5961956 Frozen ultrasonic gas suspensions
10/05/1999US5961954 Chealators of type XN1 S1 X1 for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses
10/05/1999US5961953 Magnetic resonance blood pool agents
10/05/1999US5961459 Use of hollow microcapsules in diagnosis and therapy
09/1999
09/30/1999WO1999049019A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics
09/30/1999WO1999048509A1 Urokinase plasminogen activator receptor as a target for diagnosis of metastases
09/30/1999WO1999042139A3 Hydroxyethyl starch conjugate, method for the production thereof and pharmaceuticals containing the same
09/30/1999WO1999034189A3 Process and device to solidify and thaw a polarized gas comprising xenon
09/30/1999WO1999033492A9 Method for tissue perfusion
09/30/1999DE19813773A1 Verfahren zur Herstellung von liposomalen Wirkstoffformulierungen Process for the preparation of liposomal drug formulations
09/30/1999DE19812020A1 Tandem dyes with increased Stokes shifts for fluorescence labeling of proteins, nucleic acids, cells, lipids or drugs
09/30/1999CA2324648A1 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
09/29/1999EP0944737A1 Representations of bimolecular interactions